NVAX Novavax
- 3.950
- -0.200-4.82%
- 3.999
- +0.049+1.25%
Novavax News
Novavax | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Himanshu H. Shah(6.70%),Shah Capital Management(6.66%), etc.
Novavax | SC 13D: Statement of acquisition of beneficial ownership by individuals-Himanshu H. Shah(6.70%),Shah Capital Management(6.66%), etc.
Novavax | 4: Statement of changes in beneficial ownership of securities-Officer Trizzino John
Novavax | 4: Statement of changes in beneficial ownership of securities-Officer O'Hara Elaine
Novavax | 4: Statement of changes in beneficial ownership of securities-Officer Kelly James Patrick
Novavax | 4: Statement of changes in beneficial ownership of securities-Officer Dubovsky Filip
Novavax | 4: Statement of changes in beneficial ownership of securities-Officer Casey Mark J
Novavax | 4: Statement of changes in beneficial ownership of securities-Officer Jacobs John C
Novavax | 8-K: Confidential Settlement Agreements and Release Agreements
Novavax | 4: Statement of changes in beneficial ownership of securities-Officer Kelly James Patrick
Novavax | 4: Statement of changes in beneficial ownership of securities-Officer Dubovsky Filip
Novavax | 4: Statement of changes in beneficial ownership of securities-Officer Trizzino John
Novavax | 4: Statement of changes in beneficial ownership of securities-Officer Dubovsky Filip
Novavax | 4: Statement of changes in beneficial ownership of securities-Officer Trizzino John
Novavax | 4: Statement of changes in beneficial ownership of securities-Officer Kelly James Patrick
Novavax | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Morgan Stanley(1.8%)
Novavax | 4: Statement of changes in beneficial ownership of securities-Officer O'Hara Elaine
Novavax | 8-K: Novavax Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights
Novavax | 10-K: Annual report
Novavax | 8-K: Entry into a Termination and Settlement Agreement
Analysis
Price Target
No Data
